Clinical Trial

Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2025 (before its estimated May 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effect of non-invasive ventilation (nIPPV) , (nCPAP), and nasal high flow cannula (NHFC) as a primary mode of ventilation in preterm neonates \<37 gestational week with moderate to severe RD using LUS as regard: I. Primary outcomes: Duration of non-Invasive ventilation. II. Secondary outcomes: Evaluation LUS over the 1 st 7 days of life or weaning from ventilation. Need for intubation and invasive ventilation. Duration of respiratory support. Need for surfactant. Oxygen saturation index and oxygen index. Broncho-pulmonary dysplasia; grade. Duration of hospital stay
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-10.
Status change: Not Yet Recruiting → Recruiting 2025-02-03
Trial Details
NCT Number NCT06550219
Lead Sponsor Alexandria University
Conditions Preterm, Ventilator Lung; Newborn
Enrollment 30 participants
Start Date 2024-11-20
Primary Completion 2025-05-28 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-04